Market Cap 9.36M
Revenue (ttm) 0.00
Net Income (ttm) -12.35M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 17,500
Avg Vol 18,270
Day's Range N/A - N/A
Shares Out 1.91M
Stochastic %K 48%
Beta 1.79
Analysts Strong Sell
Price Target $17.00

Company Profile

Dogwood Therapeutics, Inc., a development-stage biotechnology company, focuses on the development of medicine to treat pain and fatigue-related disorders. Its lead product candidates include IMC-1, a fixed dose combination of famciclovir and celecoxib that has completed Phase 2b clinical trial to treat fibromyalgia; Halneuron, which is in Phase 2b clinical trial for the treatment of chemotherapy-induced neuropathic pain and cancer pain, as well as pre-clinical trial for burn and ocular pain; and...

Industry: Biotechnology
Sector: Healthcare
Phone: 866 620 8655
Website: dwtx.com
Address:
44 Milton Avenue, Alpharetta, United States
Lalalilala
Lalalilala Sep. 10 at 6:25 PM
$DWTX 40% more shares than the last pump.....if Q4 results are positive, I think $14/15 would be a good price. But not beyond that at this stage. If it fails, return $1.50 and it's over. Place your bets.
1 · Reply
Skitt2k
Skitt2k Sep. 8 at 12:47 AM
$DWTX when it hit $29 was that because of positive clinical results?
0 · Reply
Skitt2k
Skitt2k Sep. 5 at 7:41 AM
$DWTX when this does eventually pop off, are we expecting a break through the 30's?
2 · Reply
cheesedonkey
cheesedonkey Sep. 4 at 3:58 PM
1 · Reply
Drainomight
Drainomight Sep. 3 at 4:57 PM
$DWTX No one is selling because they know what’s up
1 · Reply
CurrencyArbGroup
CurrencyArbGroup Aug. 23 at 11:27 AM
$DWTX DWTX Inc is a ticker that may be incorrect or represent a delisted company
3 · Reply
Drainomight
Drainomight Aug. 22 at 2:23 PM
1 · Reply
Skitt2k
Skitt2k Aug. 22 at 6:26 AM
$DWTX God is this thing due..
0 · Reply
Xvool
Xvool Aug. 21 at 12:33 PM
$DWTX pending data release - Halneuron® Chemotherapy-Induced Neuropathic Pain (“CINP”) 🚨Phase 2b study interim data readout remains on track as projected for Q4 2025 -
0 · Reply
ZacksSCR
ZacksSCR Aug. 20 at 8:20 PM
$DWTX: Over 50 Patients Enrolled Thus Far in Phase 2b Halneuron® Trial; Interim Read Out in 4Q25 Over 50 Patients Enrolled Thus Far in Phase 2b Halneuron® Trial; Interim Read Out in 4Q25 https://buff.ly/jHpJkDG
1 · Reply
Latest News on DWTX
Dogwood Therapeutics, Inc. Regains Nasdaq Compliance

Apr 3, 2025, 9:00 AM EDT - 5 months ago

Dogwood Therapeutics, Inc. Regains Nasdaq Compliance


Lalalilala
Lalalilala Sep. 10 at 6:25 PM
$DWTX 40% more shares than the last pump.....if Q4 results are positive, I think $14/15 would be a good price. But not beyond that at this stage. If it fails, return $1.50 and it's over. Place your bets.
1 · Reply
Skitt2k
Skitt2k Sep. 8 at 12:47 AM
$DWTX when it hit $29 was that because of positive clinical results?
0 · Reply
Skitt2k
Skitt2k Sep. 5 at 7:41 AM
$DWTX when this does eventually pop off, are we expecting a break through the 30's?
2 · Reply
cheesedonkey
cheesedonkey Sep. 4 at 3:58 PM
1 · Reply
Drainomight
Drainomight Sep. 3 at 4:57 PM
$DWTX No one is selling because they know what’s up
1 · Reply
CurrencyArbGroup
CurrencyArbGroup Aug. 23 at 11:27 AM
$DWTX DWTX Inc is a ticker that may be incorrect or represent a delisted company
3 · Reply
Drainomight
Drainomight Aug. 22 at 2:23 PM
1 · Reply
Skitt2k
Skitt2k Aug. 22 at 6:26 AM
$DWTX God is this thing due..
0 · Reply
Xvool
Xvool Aug. 21 at 12:33 PM
$DWTX pending data release - Halneuron® Chemotherapy-Induced Neuropathic Pain (“CINP”) 🚨Phase 2b study interim data readout remains on track as projected for Q4 2025 -
0 · Reply
ZacksSCR
ZacksSCR Aug. 20 at 8:20 PM
$DWTX: Over 50 Patients Enrolled Thus Far in Phase 2b Halneuron® Trial; Interim Read Out in 4Q25 Over 50 Patients Enrolled Thus Far in Phase 2b Halneuron® Trial; Interim Read Out in 4Q25 https://buff.ly/jHpJkDG
1 · Reply
Xvool
Xvool Aug. 20 at 7:40 PM
$DWTX $4.86 🚨 Pending Phase 2 study results 🚨 *ONLY ->1 million outstanding shares 1 million float ! $7 cash per share on balance sheet (per finviz data below) Very thin on L2 has ran from $2 to $28 in 1 day .. !
0 · Reply
HeyHoser
HeyHoser Aug. 20 at 2:48 PM
$DWTX AGAIN I ADD $4.7
1 · Reply
ByBi
ByBi Aug. 18 at 7:12 PM
$DWTX It seems like they updated their corpo presentation and took off the incoming financing for imc1 and imc2. What is there to think about ?? No more partnership ?? So if ck buy back their halneuron asset accroding to the agreement, what's next ? This is their presentations over time, with their latest updated one. 👀👇
3 · Reply
cheesedonkey
cheesedonkey Aug. 18 at 2:39 PM
0 · Reply
Xvool
Xvool Aug. 18 at 2:35 PM
$DWTX $5.10 -> 1 Million outstanding with phase 2 data pending release 🚨 *$7 cash per share on balance sheet*
1 · Reply
2TM
2TM Aug. 15 at 5:43 PM
$TIVC The company's lead drug candidate, Entolimod™ for acute radiation syndrome, is a novel TLR5 agonist that has been granted Fast Track designation and is in late stage development. Low float no shares to borrow. $GME $DWTX $CHWY. $U.
0 · Reply
gmc9
gmc9 Aug. 15 at 9:45 AM
$OTLK this can easily follow the steps of $DWTX from $2 to $27 on a news day 🔥
0 · Reply
Skitt2k
Skitt2k Aug. 11 at 5:42 AM
$DWTX they are reporting earnings this Wednesday. Wonder if it will bring any action..
1 · Reply
Drainomight
Drainomight Aug. 9 at 11:27 PM
$DWTX sleeping giant
2 · Reply
Cbtank663
Cbtank663 Aug. 7 at 5:18 PM
$DWTX https://finviz.com//news/132347/dogwood-therapeutics-announces-enrollment-of-first-fifty-patients-in-ongoing-halneuron-phase-2b-trial
0 · Reply
somaopp
somaopp Aug. 5 at 12:45 PM
$DWTX significant PM vol? perhaps news of vertex sodium channel blocker trial failure??
0 · Reply
biostocktrader_number_1
biostocktrader_number_1 Aug. 4 at 8:13 PM
$DWTX when will this fly?
0 · Reply